There are an increasing number of scientific reports that would argue the contrary.
Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin.
source
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088823/
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.
source
Researcher Dr. Tess Lawrie on Ivermectin
https://www.youtube.com/watch?v=j2EEDJuQNrI
evidence Evidence that she's an actual researcher, 115 publications long before covid and she collaborates with many other researchers. https://www.researchgate.net/profile/Theresa-Lawrie